Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FysioDanmark Hillerød ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   0.7% 0.7% 1.2% 0.7% 1.6% 0.9% 5.3% 5.3%   Credit score (0-100)   95 96 83 94 74 86 42 42   Credit rating   AA AA A AA A A BBB BBB   Credit limit (kDKK)   749.0 759.0 267.1 948.9 13.6 608.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   14,288 16,832 22,048 24,508 24,554 25,508 0.0 0.0   EBITDA   3,033 3,784 2,915 3,941 2,055 3,053 0.0 0.0   EBIT   1,414 1,148 372 1,485 -370 1,017 0.0 0.0   Pre-tax profit (PTP)   1,091.4 729.2 15.4 1,155.0 -1,382.8 876.4 0.0 0.0   Net earnings   829.0 537.8 -16.8 845.8 -1,123.0 621.8 0.0 0.0   Pre-tax profit without non-rec. items   1,091 729 15.4 1,155 -1,383 876 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   5,224 4,857 3,483 2,450 1,193 1,222 0.0 0.0   Shareholders equity total   4,506 4,144 3,906 4,526 3,174 3,560 3,191 3,191   Interest-bearing liabilities   10,496 9,873 7,829 6,178 6,524 1,361 720 720   Balance sheet total (assets)   19,701 18,482 16,187 15,946 12,843 10,422 3,912 3,912   Net Debt   10,326 9,701 6,040 2,619 3,701 358 720 720     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   14,288 16,832 22,048 24,508 24,554 25,508 0.0 0.0   Gross profit growth   9.0% 17.8% 31.0% 11.2% 0.2% 3.9% -100.0% 0.0%   Employees   18 21 41 43 43 39 0 0   Employee growth %   0.0% 16.7% 95.2% 4.9% 0.0% -9.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   19,701 18,482 16,187 15,946 12,843 10,422 3,912 3,912   Balance sheet change%   121.9% -6.2% -12.4% -1.5% -19.5% -18.8% -62.5% 0.0%   Added value   3,033.0 3,784.1 2,914.5 3,940.8 2,085.4 3,053.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   8,149 -4,172 -5,085 -4,657 -4,850 -2,826 -1,222 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.9% 6.8% 1.7% 6.1% -1.5% 4.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   10.1% 6.2% 2.4% 9.7% -1.0% 10.0% 0.0% 0.0%   ROI %   13.4% 7.9% 3.1% 12.5% -1.3% 15.3% 0.0% 0.0%   ROE %   18.1% 12.4% -0.4% 20.1% -29.2% 18.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   23.0% 22.4% 24.1% 28.4% 24.7% 34.2% 81.6% 81.6%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   340.4% 256.4% 207.2% 66.5% 180.1% 11.7% 0.0% 0.0%   Gearing %   232.9% 238.3% 200.4% 136.5% 205.6% 38.2% 22.6% 22.6%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.8% 4.5% 4.6% 5.8% 19.5% 7.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.4 0.5 0.7 0.7 0.6 0.0 0.0   Current Ratio   0.4 0.4 0.5 0.7 0.7 0.8 0.0 0.0   Cash and cash equivalent   170.2 171.9 1,789.8 3,559.3 2,823.2 1,002.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -5,820.4 -5,138.2 -3,960.6 -5,987.6 -5,020.6 -1,710.9 -360.2 -360.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   169 180 71 92 48 78 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   169 180 71 92 48 78 0 0   EBIT / employee   79 55 9 35 -9 26 0 0   Net earnings / employee   46 26 -0 20 -26 16 0 0